Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Database
Language
Publication year range
1.
Mol Syst Biol ; 6: 371, 2010 Jun 08.
Article in English | MEDLINE | ID: mdl-20531401

ABSTRACT

Recognition of microbial danger signals by toll-like receptors (TLR) causes re-programming of macrophages. To investigate kinase cascades triggered by the TLR4 ligand lipopolysaccharide (LPS) on systems level, we performed a global, quantitative and kinetic analysis of the phosphoproteome of primary macrophages using stable isotope labelling with amino acids in cell culture, phosphopeptide enrichment and high-resolution mass spectrometry. In parallel, nascent RNA was profiled to link transcription factor (TF) phosphorylation to TLR4-induced transcriptional activation. We reproducibly identified 1850 phosphoproteins with 6956 phosphorylation sites, two thirds of which were not reported earlier. LPS caused major dynamic changes in the phosphoproteome (24% up-regulation and 9% down-regulation). Functional bioinformatic analyses confirmed canonical players of the TLR pathway and highlighted other signalling modules (e.g. mTOR, ATM/ATR kinases) and the cytoskeleton as hotspots of LPS-regulated phosphorylation. Finally, weaving together phosphoproteome and nascent transcriptome data by in silico promoter analysis, we implicated several phosphorylated TFs in primary LPS-controlled gene expression.


Subject(s)
Macrophage Activation/immunology , Macrophages/immunology , Phosphoproteins/metabolism , Proteome/metabolism , Toll-Like Receptor 4/immunology , Animals , Cells, Cultured , Enzyme Activation/drug effects , Lipopolysaccharides/pharmacology , Macrophage Activation/drug effects , Macrophages/drug effects , Macrophages/enzymology , Mice , Phosphorylation/drug effects , Protein Kinases/metabolism , Signal Transduction/drug effects , Transcription Factors/metabolism , Transcriptional Activation/drug effects , Transcriptional Activation/genetics
SELECTION OF CITATIONS
SEARCH DETAIL